Tinahones F J, Cardona F, Rojo-Martínez G, Almaraz M C, Cardona I, Vázquez-Mellado J, Garrido-Sánchez L, Collantes E, Soriguer F
Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Victoria, Málaga and CIBER Fisiopatología de la obesidad y nutrición CB06/03 Instituto de Salud Carlos III, Málaga, Spain.
Br J Nutr. 2008 Jan;99(1):44-8. doi: 10.1017/S0007114507787470. Epub 2007 Aug 29.
Hyperuricaemia is one of the components of metabolic syndrome. Both oxidative stress and hyperinsulinism are important variables in the genesis of this syndrome and have a close association with uric acid (UA). We evaluated the effect of an oral glucose challenge on UA concentrations. The study included 656 persons aged 18 to 65 years. Glycaemia, insulin, UA and plasma proteins were measured at baseline and 120 min after an oral glucose tolerance test (OGTT). The baseline sample also included measurements of total cholesterol, triacylglycerol (TAG) and HDL-cholesterol. Insulin resistance was calculated with the homeostasis model assessment. UA levels were significantly lower after the OGTT (281.93 (sd 92.19) v. 267.48 (sd 90.40) micromol/l; P < 0.0001). Subjects with a drop in UA concentrations >40.86 micromol/l (>75th percentile) had higher plasma TAG levels (P = 0.0001), baseline insulin (P = 0.02) and greater insulin resistance (P = 0.034). Women with a difference in plasma concentrations of UA above the 75th percentile had higher baseline insulin levels (P = 0.019), concentration of plasma TAG (P = 0.0001) and a greater insulin resistance index (P = 0.029), whereas the only significant difference in men was the level of TAG. Multiple regression analysis showed that the basal TAG levels, insulin at 120 min, glycaemia at 120 min and waist:hip ratio significantly predicted the variance in the UA difference (r2 0.077). Levels of UA were significantly lower after the OGTT and the individuals with the greatest decrease in UA levels are those who have greater insulin resistance and higher TAG levels.
高尿酸血症是代谢综合征的组成部分之一。氧化应激和高胰岛素血症都是该综合征发生过程中的重要变量,且与尿酸(UA)密切相关。我们评估了口服葡萄糖耐量试验对UA浓度的影响。该研究纳入了656名年龄在18至65岁之间的人群。在口服葡萄糖耐量试验(OGTT)的基线和120分钟后测量血糖、胰岛素、UA和血浆蛋白。基线样本还包括总胆固醇、三酰甘油(TAG)和高密度脂蛋白胆固醇的测量。采用稳态模型评估计算胰岛素抵抗。OGTT后UA水平显著降低(281.93(标准差92.19)对267.48(标准差90.40)μmol/L;P<0.0001)。UA浓度下降>40.86μmol/L(>第75百分位数)的受试者血浆TAG水平更高(P = 0.0001)、基线胰岛素水平更高(P = 0.02)且胰岛素抵抗更强(P = 0.034)。血浆UA浓度差异高于第75百分位数的女性基线胰岛素水平更高(P = 0.019)、血浆TAG浓度更高(P = 0.0001)且胰岛素抵抗指数更高(P = 0.029),而男性唯一的显著差异是TAG水平。多元回归分析显示,基础TAG水平、120分钟时的胰岛素水平、120分钟时的血糖水平和腰臀比显著预测了UA差异的方差(r2 0.077)。OGTT后UA水平显著降低,UA水平下降幅度最大的个体是那些胰岛素抵抗更强且TAG水平更高的个体。